These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16039904

  • 1. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.
    Engelhardt B, Ransohoff RM.
    Trends Immunol; 2005 Sep; 26(9):485-95. PubMed ID: 16039904
    [Abstract] [Full Text] [Related]

  • 2. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.
    Rebenko-Moll NM, Liu L, Cardona A, Ransohoff RM.
    Curr Opin Immunol; 2006 Dec; 18(6):683-9. PubMed ID: 17010588
    [Abstract] [Full Text] [Related]

  • 3. Three or more routes for leukocyte migration into the central nervous system.
    Ransohoff RM, Kivisäkk P, Kidd G.
    Nat Rev Immunol; 2003 Jul; 3(7):569-81. PubMed ID: 12876559
    [Abstract] [Full Text] [Related]

  • 4. Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
    Engelhardt B, Ransohoff RM.
    Trends Immunol; 2012 Dec; 33(12):579-89. PubMed ID: 22926201
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E, Mancardi G, Giunti D, Corcione A, Benvenuto F, Pistoia V, Uccelli A.
    Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
    [Abstract] [Full Text] [Related]

  • 6. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO, Benes L.
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [Abstract] [Full Text] [Related]

  • 7. T-lymphocyte entry into the central nervous system.
    Hickey WF, Hsu BL, Kimura H.
    J Neurosci Res; 1991 Feb; 28(2):254-60. PubMed ID: 2033653
    [Abstract] [Full Text] [Related]

  • 8. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
    Meinl E, Krumbholz M, Hohlfeld R.
    Ann Neurol; 2006 Jun; 59(6):880-92. PubMed ID: 16718690
    [Abstract] [Full Text] [Related]

  • 9. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
    McCandless EE, Klein RS.
    Expert Rev Mol Med; 2007 Jul 19; 9(20):1-19. PubMed ID: 17637110
    [Abstract] [Full Text] [Related]

  • 10. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease.
    Schwartz M, Shechter R.
    Mol Psychiatry; 2010 Apr 19; 15(4):342-54. PubMed ID: 20332793
    [Abstract] [Full Text] [Related]

  • 11. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J, Villa A.
    Autoimmunity; 2007 Mar 19; 40(2):148-60. PubMed ID: 17453713
    [Abstract] [Full Text] [Related]

  • 12. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.
    Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, Odunsi K, Evans SS.
    Immunol Invest; 2006 Mar 19; 35(3-4):251-77. PubMed ID: 16916754
    [Abstract] [Full Text] [Related]

  • 13. The effects of natalizumab on the innate and adaptive immune system in the central nervous system.
    Stüve O.
    J Neurol Sci; 2008 Nov 15; 274(1-2):39-41. PubMed ID: 18474372
    [Abstract] [Full Text] [Related]

  • 14. T-cell trafficking competence is required for CNS invasion.
    Lees JR, Archambault AS, Russell JH.
    J Neuroimmunol; 2006 Aug 15; 177(1-2):1-10. PubMed ID: 16822552
    [Abstract] [Full Text] [Related]

  • 15. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E.
    Brain; 2006 Jan 15; 129(Pt 1):200-11. PubMed ID: 16280350
    [Abstract] [Full Text] [Related]

  • 16. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.
    Mrass P, Weninger W.
    Immunol Rev; 2006 Oct 15; 213():195-212. PubMed ID: 16972905
    [Abstract] [Full Text] [Related]

  • 17. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines.
    Engelhardt B.
    J Neurol Sci; 2008 Nov 15; 274(1-2):23-6. PubMed ID: 18573502
    [Abstract] [Full Text] [Related]

  • 18. Leukocyte traffic in the central nervous system: the participants and their roles.
    Hickey WF.
    Semin Immunol; 1999 Apr 15; 11(2):125-37. PubMed ID: 10329499
    [Abstract] [Full Text] [Related]

  • 19. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr 15; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 20. CNS dendritic cells: critical participants in CNS inflammation?
    McMahon EJ, Bailey SL, Miller SD.
    Neurochem Int; 2006 Jul 15; 49(2):195-203. PubMed ID: 16730862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.